We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ananda Pharma Plc | AQSE:ANA | Aquis Stock Exchange | Ordinary Share | GB00BDQPXQ60 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.02 | -4.21% | 0.455 | 0.40 | 0.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.475 | 0.42 | 0.475 | 1,654,057 | 16:29:58 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/3/2025 | 11:47 | ALNC |  DIRECTOR DEALINGS: Canal+, CML, Hammerson and Inchcape directors buy |
| 04/3/2025 | 07:00 | UK RNS | Ananda Pharma PLC Director/PDMR Shareholding |
| 20/2/2025 | 07:00 | UK RNS | Ananda Pharma PLC Achievement of Manufacturing Milestone for MRX1 |
| 06/2/2025 | 15:06 | UK RNS | Ananda Pharma PLC Director/PDMR Shareholding |
| 03/2/2025 | 16:35 | UK RNS | Ananda Pharma PLC Change of Registered Office |
| 03/2/2025 | 07:00 | UK RNS | Ananda Pharma PLC Ananda Pharma Appoints Viridian Capital Advisors |
| 07/1/2025 | 11:34 | UK RNS | Ananda Pharma PLC Total Voting Rights |
| 20/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Change of Name |
| 11/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Subscription to raise £150,000 |
| 09/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Further Promising Results for MRX1 |
1 Year Ananda Pharma Chart |
Intraday Ananda Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
